FdaApplication
ANDA 212609
Identifiers
- fda_app_no: ANDA212609
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
| approval_date | 2026-04-02 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NINTEDANIB ESYLATE | NINTEDANIB ESYLATE | EQ 100MG BASE | CAPSULE;ORAL |
| NINTEDANIB ESYLATE | NINTEDANIB ESYLATE | EQ 150MG BASE | CAPSULE;ORAL |
2 products